Literature DB >> 190002

2'-Deoxy-2'-azidocytidine, a new inhibitor of DNA replication in mammalian cells.

L Skoog, G Bjursell, L Thelander, T Hägerström, J Hobbs, F Eckstein.   

Abstract

Cell growth is reversibly inhibited by the nucleoside analogue, 2'-deoxy-2'-azidocytidine and the inhibition is a result of interference with DNA replication. The 5'-diphosphate of the analogue was earlier shown to specifically inactivate the enzyme ribonucleotide reductase in vitro. However, measurements of the pools of deoxyribonucleoside triphosphates in cells incubated in azidocytidine showed only minor changes which appeared to result from and not to be the cause of the inhibition of DNA replication. The DNA synthesized in polyoma-infected cells after incubation in azidocytidine showed a sedimentation pattern quite different from that seen after inhibition of DNA synthesis with arabinosyl cytosine or hydroxyurea. Experiments with nuclei isolated from azidocytidine-inhibited, polyoma-infected cells indicated (a) that the number of replicating molecules is decreased during the inhibition and (b) that upon incubation of the nuclei there is a rapid synthesis of DNA occurring in a new class of DNA molecules which are at a very early state of replication. Neither the 5'-triphosphate of azidocytidine nor the nucleoside itself inhibit DNA synthesis in vitro in isolated nuclei from polyoma-infected cells and at present the nature of the DNA-synthesis-inhibiting compound acting in the cells after addition of azidocytidine is unknown. Taken together the results suggest that azidocytidine inhibits DNA synthesis at an early stage, possible by blocking the initiation of DNA synthesis at the origin or by interfering with the elongation of newly initiated DNA molecules.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190002     DOI: 10.1111/j.1432-1033.1977.tb11261.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Polyoma DNA synthesis in isolated nuclei: evidence for defective replication forks.

Authors:  G Bjursell; V Munck; A J Therkelsen
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

2.  Effects of 2'-deoxy-2'-azidocytidine on polyoma virus DNA replication: evidence for rolling circle-type mechanism.

Authors:  G Bjursell
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

3.  2'-Deoxy-2'-azidocytidine inhibits the initiation of polyoma DNA synthesis.

Authors:  G Bjursell; L Skoog; L Thelander; G Söderman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Linear simian virus 40 DNA fragments exhibit a propensity for rolling-circle replication.

Authors:  I Deichaite; Z Laver-Rudich; D Dorsett; E Winocour
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

5.  In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

Authors:  Yohichi Kumaki; Craig W Day; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2011-09-08       Impact factor: 5.970

6.  Characterization of the autoregulation of simian virus 40 gene A.

Authors:  J C Alwine; S I Reed; G R Stark
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

7.  Cell- and Polymerase-Selective Metabolic Labeling of Cellular RNA with 2'-Azidocytidine.

Authors:  Danyang Wang; Yu Zhang; Ralph E Kleiner
Journal:  J Am Chem Soc       Date:  2020-08-14       Impact factor: 15.419

8.  Metal-free class Ie ribonucleotide reductase from pathogens initiates catalysis with a tyrosine-derived dihydroxyphenylalanine radical.

Authors:  Elizabeth J Blaesi; Gavin M Palowitch; Kai Hu; Amelia J Kim; Hannah R Rose; Rahul Alapati; Marshall G Lougee; Hee Jong Kim; Alexander T Taguchi; Kong Ooi Tan; Tatiana N Laremore; Robert G Griffin; Carsten Krebs; Megan L Matthews; Alexey Silakov; J Martin Bollinger; Benjamin D Allen; Amie K Boal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.